Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving UME and may offer a potential new treatment option for patientsVision improvements were seen in both ...

Detailed price information for Fathom Nickel Inc (FNICF) from The Globe and Mail including charting and trades.

Objective Glomerular immune complex deposition plays a central role in lupus nephritis (LN), but the prognostic relevance of individual immunoglobulin components remains unclear. This study aimed to ...

New Delhi, October 8, 2025 - The inaugural Satcom Summit at the India Mobile Congress (IMC) 2025 marked a historic moment for ...

Moderately bullish activity in Palantir Technologies (PLTR), with shares up $2.52, or 1.4%, near $181.84. Options volume roughly in line with average with 403k contracts traded and calls leading puts ...

Parnassus Mid Cap Growth Fund (Investor Shares) returned 7.90% (net of fees) for the quarter, outperforming the Russell Midcap Growth Index’s 2.78% return. Read more here.

Gilead Sciences, Inc. (Nasdaq: GILD) today shared positive data from the Phase 3 ASCENT-03 study demonstrating a highly statistically significant and clinically meaningful improvement in ...

Harbaji, W. and Abdulai, A. (2025) Factors Influencing Schoolchildren’s Obesity: A Qualitative Document Analysis of ...

The "CD47 Inhibitors Drug Market Opportunity, Clinical Application by Indications & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering.The quest for new cancer ...

The furthest intersection returns 49m at 6.1% CuEq1 and remains open at depth; These results will form part of the Mineral Resource Estimate update set for this quarterKEY POINTS Drilling from the end ...